XTAE:PPBT (Israel)  
Purple Biotech Ltd logo

Purple Biotech Ltd

₪ 0.63 (-1.71%) Dec 8
P/E:
At Loss
P/B:
0.65
Market Cap:
₪ 115.86M ($ 33.89M)
Enterprise V:
₪ 4.06M ($ 1.19M)
Volume:
41.67K
Avg Vol (2M):
38.88K
Also Trade In:
Volume:
41.67K
Market Cap ₪:
115.86M
Market Cap $:
33.89M
PE Ratio:
At Loss
Avg Vol (2-Month):
38.88K
Enterprise Value ₪:
4.06M
Enterprise Value $:
1.19M
PB Ratio:
0.65

Business Description

Description
Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, to create treatments for people with cancer. Its oncology pipeline includes NT219 and CM24.
Name Current Vs Industry Vs History
Cash-To-Debt 60.15
Equity-to-Asset 0.89
Debt-to-Equity 0.01
Debt-to-EBITDA -0.03
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 28.96
9-Day RSI 34.63
14-Day RSI 37.59
6-1 Month Momentum % -25.34
12-1 Month Momentum % -43.31

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 5.78
Quick Ratio 5.78
Cash Ratio 5.58

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -123.2
Name Current Vs Industry Vs History
ROE % -34.63
ROA % -31.37
ROIC % -84.96
ROC (Joel Greenblatt) % -2432.13
ROCE % -33.57